Jonathan Katz

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix et al. · New England Journal of Medicine · 2020 · 524 citations · Full text

Medicine, Neurology, Pharmacology +14

Immune‐mediated necrotizing myopathy associated with statins

Phyllis Grable‐Esposito, Hans Katzberg, Steven A. Greenberg et al. · Muscle & Nerve · 2009 · 338 citations

Medicine, Immunology, Pathology +17

Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)

Rongzhen Zhang, Robert G. Miller, Ron Gascon et al. · Journal of Neuroimmunology · 2008 · 327 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial

Anne‐Marie Wills, Jane Hubbard, Eric A. Macklin et al. · The Lancet · 2014 · 266 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +13